Lanza / Klimanskaya | Essential Stem Cell Methods | E-Book | sack.de
E-Book

E-Book, Englisch, 628 Seiten

Reihe: ISSN

Lanza / Klimanskaya Essential Stem Cell Methods

E-Book, Englisch, 628 Seiten

Reihe: ISSN

ISBN: 978-0-08-088525-4
Verlag: Elsevier Reference Monographs
Format: PDF
Kopierschutz: Adobe DRM (»Systemvoraussetzungen)



This is a fast-moving field, and these detailed methods will help drive advances in stem cell research. The editors have hand selected step-by-step methods from researchers with extensive reputations and expertise.
This volume, as part of the Reliable Lab Solutions series, delivers busy researchers a handy, time-saving source for the best methods and protocols in stem cells.
* Provides powerful research opportunities for those interested in perusing work in pluripotent stem cells, disease modeling, and other aspects of basic stem cell research

* Refines, organizes and updates popular methods from flagship series, Methods in Enzymology
*Highlights top downloads, enhanced with author tips and tricks and pitfalls to avoid
Lanza / Klimanskaya Essential Stem Cell Methods jetzt bestellen!

Weitere Infos & Material


1;Front Cover;1
2;Essential Stem Cell Methods;4
3;Copyright Page;5
4;Contents;6
5;Contributors;14
6;Preface;20
7;Section I: Organ-Derived Stem Cells;22
7.1;Chapter 1: Neural Stem Cells: Isolation and Characterization;24
7.1.1;1. Introduction;25
7.1.2;2. Reagents and Instrumentation;26
7.1.3;3. Methods;29
7.1.4;Acknowledgments;42
7.1.5;References;42
7.2;Chapter 2: Neural Stem Cells and Their Manipulation;44
7.2.1;1. Introduction;45
7.2.2;2. Adult Niches for Stem Cells In Vivo;46
7.2.3;3. In Vitro Manipulation of NSCs;48
7.2.4;4. Conclusions and Projections;60
7.2.5;5. Sample Protocols for the Culture and Characterization of NSCs;61
7.2.6;6. Culture of Rodent/Murine NSCs;62
7.2.7;7. Culture of Human NSCs;64
7.2.8;8. ICC of Markers to Identify Stem Cells and Differentiation Products;66
7.2.9;Acknowledgments;66
7.2.10;References;66
7.3;Chapter 3: Retinal Stem Cells;74
7.3.1;1. Introduction;75
7.3.2;2. Materials and Methods;81
7.3.3;3. Overview;89
7.3.4;References;90
7.4;Chapter 4: Dental Pulp Stem Cells;94
7.4.1;1. Introduction;95
7.4.2;2. Identification of Dental Pulp Stem Cells (DPSCs);96
7.4.3;3. Isolation of DPSCs;98
7.4.4;4. Differentiation of DPSCs;100
7.4.5;References;104
7.5;Chapter 5: Mouse Spermatogonial Stem Cells: Culture and Transplantation;108
7.5.1;1. Introduction;109
7.5.2;2. Spermatogonial Stem Cells (SSCs);110
7.5.3;3. SSC Transplantation;112
7.5.4;4. SSC Culture;119
7.5.5;5. siRNA Transfection of Cultured Mouse SSCs;126
7.5.6;6. Implications;130
7.5.7;Acknowledgments;130
7.5.8;References;131
7.6;Chapter 6: Stem Cells in the Adult Lung;134
7.6.1;1. Introduction;135
7.6.2;2. Anatomical and Cellular Diversity of the Adult Lung;136
7.6.3;3. Stem Cell Phenotypes and Niches in the Adult Lung;138
7.6.4;4. In Vivo Injury Models of the Lung;142
7.6.5;5. Ex Vivo Epithelial Tracheal Xenograft Model to Study Stem Cells Expansion in the Proximal Airway;149
7.6.6;6. In Vitro Colony-Forming Efficiency (CFE) Assay to Characterize Stem/progenitor Cell Populations in Conducting Airway Epithel;157
7.6.7;7. Models to Study Stem/Progenitor Cells of Airway SMG;162
7.6.8;Acknowledgments;164
7.6.9;References;164
7.7;Chapter 7: Pancreatic Cells and Their Progenitors;170
7.7.1;1. Introduction;171
7.7.2;2. Pancreas Development;172
7.7.3;3. Origins of Beta Cells During Postnatal Life;174
7.7.4;4. Preexisting Beta Cells;175
7.7.5;5. Ducts;176
7.7.6;6. Acini;176
7.7.7;7. Bone Marrow Cells;177
7.7.8;8. Adult Stem Cells;177
7.7.9;9. Dedifferentiation of Beta Cells;178
7.7.10;10. Summary and Perspective;178
7.7.11;11. Methods: Design of a Lineage Tracing Experiment in Mice;179
7.7.12;References;181
7.8;Chapter 8: Pluripotent Stem Cells from Germ Cells: Derivation and Maintenance;186
7.8.1;1. Introduction;187
7.8.2;2. Germ Cell Development;188
7.8.3;3. EGC Derivation;189
7.8.4;4. Characterization of EG Cultures;198
7.8.5;5. EB Formation and Analysis;203
7.8.6;6. EB-Derived Cell Formation;204
7.8.7;Acknowledgments;206
7.8.8;References;206
7.9;Chapter 9: Pluripotent Stem Cells from Amniotic Fluid and Placenta;212
7.9.1;1. Introduction;213
7.9.2;2. Amniotic Fluid and Placenta in Developmental Biology;213
7.9.3;3. Amniotic and Placental Cells for Therapy-A New Connection;214
7.9.4;4. Isolation and Characterization of Progenitor Cells;215
7.9.5;5. Differentiation of Amniotic and Placental-Derived Progenitor Cells;216
7.9.6;6. Conclusion;220
7.9.7;References;220
7.10;Chapter 10: Hematopoietic Stem and Progenitor Cells from Cord Blood;224
7.10.1;1. Introduction: Cord Blood Transplantation;225
7.10.2;2. Methodologies for Assessing Hematopoietic Progenitor and Stem Cells, as Well as EPC, Present in Human Cord Blood;232
7.10.3;3. Uses of Above Assays;248
7.10.4;References;250
7.11;Chapter 11: Hematopoietic Stem Cells from Bone Marrow: Purification and Functional Analysis;258
7.11.1;1. Introduction;259
7.11.2;2. Other HSC Surface Markers: Tie-2, Endoglin, and the SLAM Family Receptors;260
7.11.3;3. Fluorescent Dye Efflux in HSCs and the SPKLS;260
7.11.4;4. Characteristics of HSCs from Different Purification Schemes;263
7.11.5;5. Protocol of HSC Sorting with Hoechst 33342 Staining (SP Population);264
7.11.6;References;268
7.12;Chapter 12: Microarray Analysis of Stem Cells and Their Differentiation;270
7.12.1;1. Introduction;271
7.12.2;2. Overview of Microarray Technology;271
7.12.3;3. Experimental Design;274
7.12.4;4. Confirmation Studies;291
7.12.5;5. Examples of Microarray Experiments for Stem Cell Biology and Differentiation;292
7.12.6;6. Identification of "Stemness";292
7.12.7;7. Differentiation;293
7.12.8;8. Stem Cell Niches;294
7.12.9;9. Future Directions;296
7.12.10;References;296
7.13;Chapter 13: Tissue Engineering Using Adult Stem Cells;302
7.13.1;1. Introduction;303
7.13.2;2. Biomaterials;305
7.13.3;3. Angiogenic Factors;307
7.13.4;4. Adult Stem Cells for Tissue Engineering;308
7.13.5;5. Conclusion;313
7.13.6;References;313
7.14;Chapter 14: Tissue Engineering Using Mesenchymal Stem Cells;318
7.14.1;1. MSCs: Definition and Therapeutic Promise;319
7.14.2;2. Isolation and Expansion of MSCs;321
7.14.3;3. Multilineage Differentiation of MSCs;324
7.14.4;4. Clinical Translation of MSC-Based Therapies;331
7.14.5;5. Conclusions;333
7.14.6;Acknowledgments;334
7.14.7;References;334
8;Section II: Embryonic Stem Cells and Their Derivatives;340
8.1;Chapter 15: Mouse Embryonic Stem Cells;342
8.1.1;1. Historical Overview;343
8.1.2;2. Factors Affecting the Effi;ciency of Mouse ES Cell Establishment;345
8.1.3;3. Factors Affecting the Contribution of Mouse ES Cell to Chimeric Embryos;346
8.1.4;4. Critical Events During Mouse ES Cell Establishment;347
8.1.5;5. Freezing of ES Cell Lines;351
8.1.6;6. Characterization;351
8.1.7;7. Protocols;353
8.1.8;Acknowledgment;358
8.1.9;References;358
8.2;Chapter 16: Human Embryo Culture;362
8.2.1;1. Introduction;363
8.2.2;2. Human Embryo Development;363
8.2.3;3. Embryo Biopsy;366
8.2.4;4. Human Embryo Culture;368
8.2.5;5. Results;372
8.2.6;References;375
8.3;Chapter 17: Human Embryonic Stem Cells: Derivation and Maintenance;380
8.3.1;1. Introduction;381
8.3.2;2. Derivation of hES Cell Lines;381
8.3.3;3. Maintenance of hES Cells;386
8.3.4;4. Conclusion;389
8.3.5;Acknowledgments;389
8.3.6;References;390
8.4;Chapter 18: Human Embryonic Stem Cells: Characterization and Evaluation;394
8.4.1;1. Introduction;395
8.4.2;2. Characterization of Undifferentiated hESCs;396
8.4.3;3. Conclusion;410
8.4.4;Acknowledgments;410
8.4.5;References;410
8.5;Chapter 19: Human Embryonic Stem Cells: Feeder-Free Culture ;416
8.5.1;1. Introduction;417
8.5.2;2. Methods for Feeder Layer-Free Culture of hESCs;422
8.5.3;Acknowledgments;425
8.5.4;References;425
8.6;Chapter 20: Neural Stem Cells, Neurons, and Glia from Embryonic Stem Cells;428
8.6.1;1. Introduction;429
8.6.2;2. Protocols;430
8.6.3;3. Summary;442
8.6.4;4. Media and Reagents;443
8.6.5;Acknowledgments;444
8.6.6;References;445
8.7;Chapter 21: Hematopoietic Cell Differentiation from Embryonic Stem Cells;446
8.7.1;1. Introduction;447
8.7.2;2. Methods;457
8.7.3;References;472
8.8;Chapter 22: Cardiomyocyte Differentiation from Embryonic Stem Cells;480
8.8.1;1. Introduction;481
8.8.2;2. Embryoid Body Generation;482
8.8.3;3. Cardiomyocyte Differentiation;491
8.8.4;4. Enrichment of Cardiomyocytes;492
8.8.5;5. Conclusion;494
8.8.6;References;495
8.9;Chapter 23: Insulin-Producing Cells from Mouse Embryonic Stem Cells;498
8.9.1;1. Introduction;499
8.9.2;2. Materials and Methods;506
8.9.3;3. Results;514
8.9.4;4. Summary;515
8.9.5;References;517
8.10;Chapter 24: Transgene Expression and RNA Interference in Embryonic Stem Cells;522
8.10.1;1. Retrovirus Expression Vectors and ESCs;523
8.10.2;2. RNA Interference and ESCs;524
8.10.3;3. siRNA Expression Vector Design;525
8.10.4;4. Retrovirus Production;526
8.10.5;5. Retroviral and Lentiviral Gene Transfer into Mouse and Human ESCs;527
8.10.6;6. Transgene and siRNA Expression in Mouse and hESCs;528
8.10.7;7. Biotechnological and Medical Applications;532
8.10.8;Acknowledgments;533
8.10.9;References;533
8.11;Chapter 25: Lentiviral Vector-Mediated Gene Delivery into Human Embryonic Stem Cells;538
8.11.1;1. Introduction;540
8.11.2;2. Design of HIV-1 Based Vectors for Transduction of hESCs;544
8.11.3;3. Generation of Recombinant Viral Particles;548
8.11.4;4. Transduction of hESCs;550
8.11.5;5. Measurement of Transduction Efficiency;553
8.11.6;6. Enrichment for Transduced hESCs Expressing High Levels of the Transgene;554
8.11.7;7. Determination of Viral Titer;556
8.11.8;References;557
8.12;Chapter 26: Engineering Embryonic Stem Cells with Recombinase Systems;562
8.12.1;1. Introduction;563
8.12.2;2. Site-Specific Recombination;564
8.12.3;3. Designing Substrates for Site-Specific Recombination;568
8.12.4;4. Generation of Conditional Alleles;574
8.12.5;5. Recombinase Mediated Cassette Exchange (RMCE);579
8.12.6;6. Molecular Switches;580
8.12.7;7. Protocols;583
8.12.8;Acknowledgments;592
8.12.9;References;593
8.13;Chapter 27: Tissue Engineering Using Embryonic Stem Cells;600
8.13.1;1. Introduction;601
8.13.2;2. Special Considerations when using hESCs as the Cell Source for TE;602
8.13.3;3. Growing hESCs in Defined Animal-Free Conditions;602
8.13.4;4. Obtaining the Desired Cell Population;603
8.13.5;5. Choosing the Right Scaffold;604
8.13.6;6. Scaling-Up a Regulable Bioprocess;604
8.13.7;7. hESC-Derived Connective Tissue Progenitors for TE;605
8.13.8;8. Culture and Maintenance of hESC on MEF Feeders;605
8.13.9;9. Harvesting Samples for Analyses;610
8.13.10;References;614
9;Index;616


Ihre Fragen, Wünsche oder Anmerkungen
Vorname*
Nachname*
Ihre E-Mail-Adresse*
Kundennr.
Ihre Nachricht*
Lediglich mit * gekennzeichnete Felder sind Pflichtfelder.
Wenn Sie die im Kontaktformular eingegebenen Daten durch Klick auf den nachfolgenden Button übersenden, erklären Sie sich damit einverstanden, dass wir Ihr Angaben für die Beantwortung Ihrer Anfrage verwenden. Selbstverständlich werden Ihre Daten vertraulich behandelt und nicht an Dritte weitergegeben. Sie können der Verwendung Ihrer Daten jederzeit widersprechen. Das Datenhandling bei Sack Fachmedien erklären wir Ihnen in unserer Datenschutzerklärung.